David B. Snow Jr - May 21, 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
Director
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
May 21, 2025
Transactions value $
$0
Form type
4
Date filed
5/23/2025, 04:06 PM
Previous filing
May 24, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SNOW DAVID B JR Director C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, FLOOR 17, NEW YORK /s/ Adam C. Vandervoort, Attorney-in-Fact 2025-05-23 0001203676

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Award +17.5K +26.23% 84K May 21, 2025 Direct F1
holding TDOC Common Stock 52K May 21, 2025 By the David B. Snow, Jr. Irrevocable Trust dated December 12, 2012 F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -17.5K -100% $0.00 0 May 21, 2025 Common Stock 17.5K Direct F1, F3
transaction TDOC Restricted Stock Units Award $0 +29K $0.00 29K May 22, 2025 Common Stock 29K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 The shares are held of record by the David B. Snow, Jr. Irrevocable Trust dated December 12, 2012 for the benefit of the reporting person's children and for which the reporting person's spouse serves as trustee.
F3 On May 23, 2024, the reporting person was granted 17,467 restricted stock units, vesting in full on May 21, 2025.
F4 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F5 The restricted stock units vest in full on the earlier of (i) May 22, 2026 and (ii) the day immediately preceding the issuer's 2026 annual meeting of stockholders.